Normon S.A. aumenta su vademécum con el lanzamiento de Ranolazina Normon 375 mg comprimidos de liberación prolongada EFG, 60 comprimidos, Ranolazina Normon 500 mg comprimidos de liberación prolongada EFG, 60 comprimidos y Ranolazina Normon 750 mg comprimidos de liberación prolongada EFG, 60 comprimidos. Este medicamento está indicado en adultos como terapia complementaria para el tratamiento sinto...
This article is for subscribers only
Login to your account to continue reading.
This publication is restricted to registered pharmacists, and its dissemination among the general public or other health professionals is not intended.
Listen to this article
